Theraclion SA (EPA:ALTHE)
France · Delayed Price · Currency is EUR 0.7300
+0.0200 (2.82%)
Jun 3, 2026, 5:35 PM CET
Theraclion Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.65 | 0.83 | 1.82 | 1.24 | 1.48 |
Other Revenue | - | -0 | - | - | - |
| 0.65 | 0.83 | 1.82 | 1.24 | 1.48 | |
Revenue Growth (YoY) | -21.35% | -54.51% | 47.49% | -16.58% | 99.05% |
Cost of Revenue | 3.72 | 4.66 | 2.9 | 4.29 | 2.88 |
Gross Profit | -3.07 | -3.83 | -1.08 | -3.05 | -1.4 |
Selling, General & Admin | 3.67 | 3.36 | 3.15 | 3.1 | 3.14 |
Other Operating Expenses | 0.61 | -0.6 | -1.29 | -0.03 | -0.14 |
Operating Expenses | 4.68 | 3.25 | 2.07 | 3.26 | 3.14 |
Operating Income | -7.75 | -7.08 | -3.15 | -6.31 | -4.53 |
Interest Expense | -0.16 | -0.02 | -0.03 | -0.04 | -0.07 |
Interest & Investment Income | 0.02 | 0.01 | 0.03 | - | - |
Earnings From Equity Investments | - | 0.16 | - | - | - |
Currency Exchange Gain (Loss) | - | - | -0.03 | 0.03 | -0.08 |
Other Non Operating Income (Expenses) | 0 | -0 | -1.89 | -0.02 | -0.08 |
EBT Excluding Unusual Items | -7.89 | -6.93 | -5.08 | -6.34 | -4.77 |
Gain (Loss) on Sale of Investments | -0.01 | -0.01 | -0.03 | 0.02 | 0.1 |
Gain (Loss) on Sale of Assets | 0 | - | 0 | - | -0 |
Asset Writedown | 1.37 | 0.18 | - | - | - |
Other Unusual Items | - | 0.03 | 0.38 | 0.35 | 0.03 |
Pretax Income | -6.53 | -6.74 | -4.72 | -5.97 | -4.64 |
Income Tax Expense | -0.84 | -0.98 | -1.05 | -1 | -0.88 |
Net Income | -5.69 | -5.76 | -3.68 | -4.96 | -3.76 |
Net Income to Common | -5.69 | -5.76 | -3.68 | -4.96 | -3.76 |
Shares Outstanding (Basic) | 60 | 46 | 46 | 32 | 23 |
Shares Outstanding (Diluted) | 60 | 46 | 46 | 32 | 23 |
Shares Change (YoY) | 29.27% | 1.16% | 42.94% | 40.51% | 40.73% |
EPS (Basic) | -0.10 | -0.12 | -0.08 | -0.16 | -0.17 |
EPS (Diluted) | -0.10 | -0.12 | -0.08 | -0.16 | -0.17 |
Free Cash Flow | -7.16 | -1.96 | -2.6 | -5.59 | -4.03 |
Free Cash Flow Per Share | -0.12 | -0.04 | -0.06 | -0.17 | -0.18 |
Gross Margin | - | - | -59.29% | -246.91% | -94.22% |
Operating Margin | -1188.04% | -853.80% | -173.01% | -510.54% | -306.22% |
Profit Margin | -872.70% | -694.45% | -201.68% | -401.83% | -253.92% |
Free Cash Flow Margin | -1098.01% | -236.19% | -142.52% | -452.38% | -272.26% |
EBITDA | -7.35 | -6.58 | -2.95 | -6.13 | -4.4 |
EBITDA Margin | - | - | -161.73% | - | -297.36% |
D&A For EBITDA | 0.4 | 0.5 | 0.21 | 0.18 | 0.13 |
EBIT | -7.75 | -7.08 | -3.15 | -6.31 | -4.53 |
EBIT Margin | - | - | -173.01% | - | - |
Revenue as Reported | 2.32 | 2.16 | 3.92 | 1.37 | 1.71 |